CONTINUING EDUCATION (CE) LANGUAGE

Title:                   Management of Anemia in IBD

Date:                   May 20, 2026

Location:             Online

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

ACCME provider number: 0005000

Credit Designation Statement

NASPGHAN designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ABP MOC Part 2 Credits

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.5 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Participant must complete the assessment within 30 days of the activity.

Iron deficiency anemia is one of the most common - and often overlooked - complications of pediatric IBD, making timely diagnosis and effective treatment essential to improving patient outcomes.  Management of Anemia in IBD will bring together experts in pediatric gastroenterology and hematology for a practical, case-based discussion on current evidence, treatment options, and real-world strategies for managing IDA in children with IBD.

Attendees will learn best practices for diagnosing and treating iron deficiency anemia in pediatric IBD, including considerations for oral versus intravenous iron supplementation, safety, efficacy, and patient-centered decision-making. The live session will highlight practical strategies for optimizing iron repletion while managing active inflammation, and expert panelists will share real-world clinical insights on common challenges in diagnosis, treatment response, and long-term management.  The webinar will also incorporate key insights from the NASPGHAN IBD Committee position paper, Anemia in Children with Inflammatory Bowel Disease, to help attendees better understand the current clinical landscape and apply evidence-based approaches to improve patient outcomes.